Evaluating The Effect Of Morphine On Obstructive Sleep Apnea
Funder
National Health and Medical Research Council
Funding Amount
$534,303.00
Summary
Prescription opiate poisoning deaths have increased substantially in recent years which may be worsened by population increases in obesity and related obstructive sleep apnea. However, no proper clinical trial has ever investigated the effect of an opiate on obstructive sleep apnea, which is the aim of the proposed trial. The study will be important in understanding ways to reduce opiate realted deaths and may also provide insights into new treatment methods for snoring and sleep apnea.
The First Placebo-controlled Trial Of Opioid Analgesics For Acute Spinal Pain
Funder
National Health and Medical Research Council
Funding Amount
$1,024,067.00
Summary
Despite the widespread and increasing use of opioid analgesics, there is a complete lack of evidence on their efficacy in acute spinal pain. Concerns are also being raised because of the risks of potentially serious adverse events associated with opioid analgesics. In this world-first study, we will establish whether using opioid analgesics can effective reduce pain in people with acute spinal pain and provide rigorous evidence to inform the safe and appropriate use of this medicine.
Improving The Treatment Of Breathlessness – A Phase III Randomised, Controlled Trial Of Sustained Release Morphine For The Symptomatic Treatment Of Chronic Refractory Breathlessness. A Palliative Care Clinical Studies Collaborative Study
Funder
National Health and Medical Research Council
Funding Amount
$902,732.00
Summary
More than 300000 Australians are chronically short of breath at rest or on minimal exertion despite optimal treatment of the underlying causes of their breathlessness, of whom 70000 cannot leave home. No medication in the world is registered to treat this. There is evidence that regular, low dose morphine safely helps breathlessness. This study will help clinicians adjust doses more effectively and understand whether using an additional medication to reduce anxiety helps relieve breathlessness.